| For: |
Sebastiani G, Walker AP. |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i35/4673.htm |
| Number | Citing Articles |
| 1 |
Maha Guindi. Practical Hepatic Pathology: A Diagnostic Approach. 2011; doi: 10.1016/B978-0-443-06803-4.00014-9
|
| 2 |
U Wollina, E Köstler, A Koch, H Riedel, U Stölzel. Does chloroquine therapy of porphyria cutanea tarda influence liver pathology?. International Journal of Dermatology 2009; 48(11) doi: 10.1111/j.1365-4632.2009.04205.x
|
| 3 |
Stefan G. Hübscher. Practical Hepatic Pathology: A Diagnostic Approach. 2011; doi: 10.1016/B978-0-443-06803-4.00030-7
|
| 4 |
Maha Guindi. Practical Hepatic Pathology: a Diagnostic Approach. 2018; doi: 10.1016/B978-0-323-42873-6.00011-1
|
| 5 |
Rossana Paganoni, André Lechel, Maja Vujic Spasic. Iron at the Interface of Hepatocellular Carcinoma. International Journal of Molecular Sciences 2021; 22(8) doi: 10.3390/ijms22084097
|
| 6 |
Carine Fillebeen, Kostas Pantopoulos. Iron inhibits replication of infectious hepatitis C virus in permissive Huh7.5.1 cells. Journal of Hepatology 2010; 53(6) doi: 10.1016/j.jhep.2010.04.044
|
| 7 |
Rahul Nema, Abhinav Sengupta, Arvind Kumar, Naveet Wig. Cyclical haematological changes in a case of hypopituitarism. BMJ Case Reports 2021; 14(8) doi: 10.1136/bcr-2021-243421
|
| 8 |
Jing Ma, Zhi-Qiang Song, Fu-Hua Yan, Jie Tian. Separation of Hepatic Iron and Fat by Dual-Source Dual-Energy Computed Tomography Based on Material Decomposition: An Animal Study. PLoS ONE 2014; 9(10) doi: 10.1371/journal.pone.0110964
|
| 9 |
Avital Y. O’Glasser, David L. Scott, Christopher L. Corless, Atif Zaman, Anna Sasaki, Deepak V. Gopal, Stephen C. Rayhill, Susan L. Orloff, John M. Ham, John M. Rabkin, Ken Flora, Crispin H. Davies, Craig S. Broberg, Jonathan M. Schwartz. Hepatic and cardiac iron overload among patients with end‐stage liver disease referred for liver transplantation. Clinical Transplantation 2010; 24(5) doi: 10.1111/j.1399-0012.2009.01136.x
|
| 10 |
Mark R. Bleackley, Ann Y.K. Wong, David M. Hudson, Christopher H-Y. Wu, Ross T.A. MacGillivray. Blood Iron Homeostasis: Newly Discovered Proteins and Iron Imbalance. Transfusion Medicine Reviews 2009; 23(2) doi: 10.1016/j.tmrv.2008.12.001
|
| 11 |
Rahul Kumar, Amritesh Kumar, Aayush Kumar Tiwari, MD Nasiruddin Khan, Mohit Kumar, Moidul Islam Judder. <b>Review Article on: AI-Driven Precision Medicine in Liver Disease: Microbiome and Nanotechnology Integration</b>. Pan-African Journal of Health and Psychological Sciences 2026; 2(2) doi: 10.64261/m76tpv25
|
| 12 |
D. E. Ivanoshchuk, S. V. Mikhailova, I. V. Kulikov, V. N. Maksimov, M. I. Voevoda, A. G. Romashchenko.
CCR5, CCR2, apoE, p53, ITGB3, and HFE gene polymorphism in Western Siberian long livers. Advances in Gerontology 2013; 3(2) doi: 10.1134/S2079057013020082
|
| 13 |
Dong-Mei Zou, Dong-Dong Rong, Hong Zhao, Li Su, Wan-Ling Sun. Improvement of chronic hepatitis B by iron chelation therapy in a patient with iron overload. Medicine 2017; 96(52) doi: 10.1097/MD.0000000000009566
|
| 14 |
Kostas Pantopoulos. Function of the hemochromatosis protein HFE: Lessons from animal models. World Journal of Gastroenterology 2008; 14(45): 6893-6901 doi: 10.3748/wjg.14.6893
|
| 15 |
Salah Adlat, Alexandra M. Vázquez Salgado, Markcus Lee, Dingzi Yin, Kirk J. Wangensteen. Emerging and potential use of CRISPR in human liver disease. Hepatology 2025; 82(1) doi: 10.1097/HEP.0000000000000578
|
| 16 |
G. Sebastiani, D. Tempesta, A. Alberti. Hepatic iron overload is common in chronic hepatitis B and is more severe in patients coinfected with hepatitis D virus. Journal of Viral Hepatitis 2012; 19(2) doi: 10.1111/j.1365-2893.2011.01508.x
|
| 17 |
Carine Fillebeen, Kostas Pantopoulos. Reply to: Is there any association between HCV multiplication and iron induced liver injury in chronic hepatitis C?. Journal of Hepatology 2011; 55(1) doi: 10.1016/j.jhep.2011.01.004
|
| 18 |
Sayed Hossein Davoodi, Yasaman Jamshidi-Naeini, Saeideh Esmaeili, Sara Sohrabvandi, Amir M. Mortazavian. The Dual Nature of Iron in Relation to Cancer: A Review. Iranian Journal of Cancer Prevention 2016; (In Press) doi: 10.17795/ijcp-5494
|
| 19 |
V. M. Mitsura, T. L. Krasavtsev, E. V. Voropaev, O. Yu. Baranov, I. V. Paltsev, A. L. Kalinin. THE FREQUENCY OF HFE GENE MUTATIONS C282Y AND H63D REVEALING IN PATIENTS WITH CHRONIC HEPATITIS AND LIVER CIRRHOSIS OF DIFFERENT ETIOLOGY. Health and Ecology Issues 2008; (2) doi: 10.51523/2708-6011.2008-5-2-12
|
| 20 |
Pierre Bedossa, David E. Kleiner. Alcoholic and Non-Alcoholic Fatty Liver Disease. 2016; doi: 10.1007/978-3-319-20538-0_12
|
| 21 |
Dietmar Enko, Michael Novy, Christian Oberkanins, Gernot Kriegshäuser. Reverse-hybridization resolves a rare HFE genotype untypable by real-time PCR and melting curve analysis in a patient with hyperferritinemia and alcoholic liver disease. Clinical Chemistry and Laboratory Medicine (CCLM) 2019; 57(9) doi: 10.1515/cclm-2018-1260
|
| 22 |
William E. Winter, Lindsay A. L. Bazydlo, Neil S. Harris. The Molecular Biology of Human Iron Metabolism. Laboratory Medicine 2014; 45(2) doi: 10.1309/LMF28S2GIMXNWHMM
|
| 23 |
Stefan G. Hübscher. Practical Hepatic Pathology: a Diagnostic Approach. 2018; doi: 10.1016/B978-0-323-42873-6.00024-X
|
| 24 |
Stefan G. Hübscher. Role of liver biopsy in disorders of iron metabolism. Diagnostic Histopathology 2008; 14(12) doi: 10.1016/j.mpdhp.2008.09.001
|
| 25 |
Julia R. Nunley, Marc E. Grossman, Warren W. Piette. Dermatological Signs of Internal Disease. 2009; doi: 10.1016/B978-1-4160-6111-3.00030-6
|
| 26 |
Margherita Sini, Orazio Sorbello, Alberto Civolani, Luigi Demelia. Hemochromatosis Gene Mutations: Prevalence and Effects on Pegylated-Interferon and Ribavirin Therapy Response in Chronic Hepatitis C in Sardinia. Journal of Clinical and Experimental Hepatology 2012; 2(3) doi: 10.1016/j.jceh.2012.06.004
|
| 27 |
Giada Sebastiani, Kostas Gkouvatsos, Carmen Maffettone, Graziella Busatto, Maria Guido, Kostas Pantopoulos, Young Nyun Park. Accelerated CCl4-Induced Liver Fibrosis in Hjv-/- Mice, Associated with an Oxidative Burst and Precocious Profibrogenic Gene Expression. PLoS ONE 2011; 6(9) doi: 10.1371/journal.pone.0025138
|
| 28 |
Surjit Kaila Srai, Paul Sharp. Iron Physiology and Pathophysiology in Humans. 2012; doi: 10.1007/978-1-60327-485-2_1
|
| 29 |
Giada Sebastiani, Kostas Pantopoulos. Cellular and Molecular Biology of Metals. 2010; doi: 10.1201/9781420059984-c13
|
| 30 |
Luís COSTA-MATOS, Paulo BATISTA, Nuno MONTEIRO, Pedro HENRIQUES, Fernando GIRÃO, Armando CARVALHO. HFE MUTATIONS AND IRON OVERLOAD IN PATIENTS WITH ALCOHOLIC LIVER DISEASE. Arquivos de Gastroenterologia 2013; 50(1) doi: 10.1590/S0004-28032013000100008
|
| 31 |
Richard Kirsch, Ralph Kirsch. Nutrition, Diet Therapy, and the Liver. 2009; doi: 10.1201/9781420085501.ch7
|
| 32 |
Miriam Sandnes, Rune J. Ulvik, Marta Vorland, Håkon Reikvam. Hyperferritinemia—A Clinical Overview. Journal of Clinical Medicine 2021; 10(9) doi: 10.3390/jcm10092008
|
| 33 |
Douglas B. Kell. Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples. Archives of Toxicology 2010; 84(11) doi: 10.1007/s00204-010-0577-x
|